Concepts (355)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 592 | 0.940 |
Why?
|
| Testosterone | 9 | 2013 | 181 | 0.930 |
Why?
|
| Veterans | 8 | 2020 | 115 | 0.900 |
Why?
|
| Atherosclerosis | 3 | 2013 | 131 | 0.760 |
Why?
|
| Milk, Human | 5 | 2023 | 29 | 0.690 |
Why?
|
| United States Department of Veterans Affairs | 9 | 2020 | 28 | 0.640 |
Why?
|
| Primary Health Care | 7 | 2018 | 283 | 0.620 |
Why?
|
| Prediabetic State | 2 | 2014 | 51 | 0.550 |
Why?
|
| Middle Aged | 32 | 2023 | 9642 | 0.520 |
Why?
|
| Cholesterol | 2 | 2013 | 194 | 0.480 |
Why?
|
| Hyperlipidemias | 2 | 2013 | 35 | 0.470 |
Why?
|
| Androgens | 1 | 2013 | 87 | 0.460 |
Why?
|
| Male | 45 | 2023 | 18870 | 0.460 |
Why?
|
| Anticholesteremic Agents | 1 | 2013 | 23 | 0.460 |
Why?
|
| Aged | 25 | 2023 | 6448 | 0.460 |
Why?
|
| Aging | 4 | 2013 | 639 | 0.450 |
Why?
|
| Humans | 59 | 2023 | 34853 | 0.450 |
Why?
|
| Insurance, Health | 1 | 2013 | 120 | 0.430 |
Why?
|
| Quality of Health Care | 4 | 2016 | 136 | 0.430 |
Why?
|
| Heart Failure | 3 | 2020 | 230 | 0.420 |
Why?
|
| Female | 38 | 2023 | 19873 | 0.410 |
Why?
|
| Truth Disclosure | 1 | 2011 | 24 | 0.410 |
Why?
|
| Stereotyping | 1 | 2011 | 40 | 0.400 |
Why?
|
| United States | 20 | 2020 | 3894 | 0.400 |
Why?
|
| Social Support | 2 | 2012 | 356 | 0.360 |
Why?
|
| Adult | 21 | 2023 | 11034 | 0.350 |
Why?
|
| Smoking Cessation | 3 | 2023 | 487 | 0.340 |
Why?
|
| Lower Extremity | 2 | 2019 | 38 | 0.340 |
Why?
|
| Double-Blind Method | 9 | 2023 | 269 | 0.340 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2019 | 60 | 0.330 |
Why?
|
| Lipids | 3 | 2006 | 222 | 0.330 |
Why?
|
| Hypertension | 3 | 2021 | 770 | 0.320 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2011 | 375 | 0.310 |
Why?
|
| Telemedicine | 2 | 2020 | 163 | 0.300 |
Why?
|
| Health Services | 2 | 2009 | 53 | 0.300 |
Why?
|
| Muscle, Skeletal | 6 | 2006 | 257 | 0.280 |
Why?
|
| Medication Adherence | 2 | 2021 | 165 | 0.280 |
Why?
|
| Disease Management | 3 | 2019 | 61 | 0.280 |
Why?
|
| Blood Viscosity | 3 | 2021 | 4 | 0.280 |
Why?
|
| Parkinson Disease | 2 | 2019 | 167 | 0.280 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2018 | 26 | 0.270 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2016 | 19 | 0.260 |
Why?
|
| Adolescent | 10 | 2023 | 5035 | 0.250 |
Why?
|
| Infant Formula | 2 | 2016 | 13 | 0.250 |
Why?
|
| Hyperthyroidism | 1 | 2023 | 5 | 0.240 |
Why?
|
| Iodine | 1 | 2023 | 6 | 0.240 |
Why?
|
| Dietary Proteins | 2 | 2017 | 30 | 0.240 |
Why?
|
| Atrial Flutter | 1 | 2023 | 7 | 0.240 |
Why?
|
| Oligosaccharides | 1 | 2023 | 24 | 0.240 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 2333 | 0.230 |
Why?
|
| Retrospective Studies | 8 | 2023 | 1961 | 0.230 |
Why?
|
| Infant Nutritional Physiological Phenomena | 3 | 2016 | 35 | 0.230 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2002 | 13 | 0.220 |
Why?
|
| Sampling Studies | 1 | 2002 | 60 | 0.220 |
Why?
|
| Microcirculation | 2 | 2019 | 39 | 0.220 |
Why?
|
| Health Care Surveys | 1 | 2002 | 136 | 0.210 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 105 | 0.210 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 13 | 0.210 |
Why?
|
| Hypoglycemic Agents | 3 | 2023 | 152 | 0.210 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2016 | 44 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2018 | 984 | 0.200 |
Why?
|
| Birth Weight | 4 | 2016 | 93 | 0.200 |
Why?
|
| Ischemic Attack, Transient | 1 | 2021 | 20 | 0.200 |
Why?
|
| Young Adult | 5 | 2018 | 4012 | 0.200 |
Why?
|
| Mental Disorders | 2 | 2008 | 285 | 0.180 |
Why?
|
| Cross-Sectional Studies | 6 | 2016 | 2561 | 0.180 |
Why?
|
| Tobacco Use Disorder | 1 | 2023 | 229 | 0.180 |
Why?
|
| California | 4 | 2012 | 436 | 0.180 |
Why?
|
| Sulfonylurea Compounds | 1 | 2019 | 12 | 0.180 |
Why?
|
| Hydroxychloroquine | 1 | 2019 | 15 | 0.180 |
Why?
|
| HIV Infections | 2 | 2011 | 2207 | 0.180 |
Why?
|
| Nicotine | 3 | 2023 | 238 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2020 | 202 | 0.170 |
Why?
|
| Dementia | 2 | 2012 | 133 | 0.170 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 20 | 0.170 |
Why?
|
| Metformin | 1 | 2019 | 64 | 0.170 |
Why?
|
| Weight Gain | 3 | 2015 | 128 | 0.170 |
Why?
|
| Cushing Syndrome | 1 | 2018 | 5 | 0.170 |
Why?
|
| Aspirin | 1 | 2018 | 45 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2018 | 43 | 0.160 |
Why?
|
| Depression | 2 | 2016 | 664 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 284 | 0.160 |
Why?
|
| Mass Screening | 3 | 2014 | 427 | 0.160 |
Why?
|
| Caregivers | 2 | 2012 | 167 | 0.160 |
Why?
|
| Lanthanum | 1 | 2017 | 2 | 0.160 |
Why?
|
| Hypoalbuminemia | 1 | 2017 | 4 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2019 | 1349 | 0.160 |
Why?
|
| Bone Diseases | 1 | 2017 | 18 | 0.150 |
Why?
|
| Benzamides | 1 | 2018 | 76 | 0.150 |
Why?
|
| Fatty Liver | 1 | 2018 | 56 | 0.150 |
Why?
|
| Risk Factors | 5 | 2023 | 3414 | 0.150 |
Why?
|
| Body Composition | 2 | 2011 | 146 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2021 | 613 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2002 | 465 | 0.150 |
Why?
|
| Food, Fortified | 2 | 2014 | 17 | 0.150 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 41 | 0.150 |
Why?
|
| Internet | 1 | 2018 | 204 | 0.150 |
Why?
|
| Prospective Studies | 6 | 2019 | 1353 | 0.140 |
Why?
|
| Adenoviridae | 1 | 2016 | 59 | 0.140 |
Why?
|
| Diabetic Retinopathy | 1 | 2017 | 65 | 0.140 |
Why?
|
| Infant, Premature | 2 | 2014 | 128 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2016 | 43 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2017 | 119 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2015 | 34 | 0.140 |
Why?
|
| Infant, Newborn | 5 | 2023 | 871 | 0.140 |
Why?
|
| Receptors, Androgen | 3 | 2006 | 122 | 0.140 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 438 | 0.140 |
Why?
|
| Drug Monitoring | 1 | 2015 | 17 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2016 | 97 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 104 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2016 | 65 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2016 | 166 | 0.130 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 48 | 0.130 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 30 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2015 | 93 | 0.130 |
Why?
|
| Odds Ratio | 3 | 2006 | 517 | 0.130 |
Why?
|
| Breast Feeding | 1 | 2016 | 105 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2015 | 53 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2016 | 231 | 0.130 |
Why?
|
| Time Factors | 6 | 2019 | 1681 | 0.120 |
Why?
|
| Triglycerides | 2 | 2021 | 129 | 0.120 |
Why?
|
| Health Promotion | 2 | 2019 | 588 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2013 | 429 | 0.120 |
Why?
|
| Morphine Dependence | 1 | 2013 | 25 | 0.120 |
Why?
|
| Waist Circumference | 1 | 2014 | 82 | 0.120 |
Why?
|
| Insulin | 1 | 2015 | 224 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 50 | 0.120 |
Why?
|
| Drug Therapy, Combination | 3 | 2019 | 217 | 0.120 |
Why?
|
| Feeding Behavior | 2 | 2016 | 418 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2013 | 69 | 0.110 |
Why?
|
| Morphine | 1 | 2013 | 80 | 0.110 |
Why?
|
| Nurse Practitioners | 2 | 2021 | 14 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2022 | 233 | 0.110 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 11 | 0.110 |
Why?
|
| Medicaid | 1 | 2013 | 102 | 0.110 |
Why?
|
| Community Health Services | 1 | 2014 | 175 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 16 | 0.110 |
Why?
|
| Eating | 1 | 2013 | 152 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2018 | 874 | 0.110 |
Why?
|
| Case Management | 1 | 2012 | 21 | 0.110 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2012 | 28 | 0.110 |
Why?
|
| Dietary Fats | 2 | 2011 | 115 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 176 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 58 | 0.100 |
Why?
|
| Mental Health Services | 1 | 2012 | 108 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2020 | 1422 | 0.100 |
Why?
|
| Asthma | 1 | 2015 | 363 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2008 | 187 | 0.090 |
Why?
|
| Vitamin D | 1 | 2012 | 176 | 0.090 |
Why?
|
| Needs Assessment | 2 | 2009 | 159 | 0.090 |
Why?
|
| Infant | 4 | 2016 | 1014 | 0.090 |
Why?
|
| Hospitals, Veterans | 3 | 2007 | 16 | 0.090 |
Why?
|
| Cholesterol, LDL | 2 | 2007 | 63 | 0.090 |
Why?
|
| United States Indian Health Service | 1 | 2009 | 2 | 0.090 |
Why?
|
| Lactose | 1 | 2009 | 13 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2013 | 775 | 0.090 |
Why?
|
| Regional Blood Flow | 2 | 2019 | 47 | 0.090 |
Why?
|
| Hormone Replacement Therapy | 2 | 2006 | 41 | 0.090 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 63 | 0.090 |
Why?
|
| Cross-Over Studies | 2 | 2019 | 102 | 0.080 |
Why?
|
| Nutritional Requirements | 1 | 2009 | 37 | 0.080 |
Why?
|
| Health Services Research | 1 | 2009 | 133 | 0.080 |
Why?
|
| Patient Care Management | 1 | 2008 | 6 | 0.080 |
Why?
|
| Bisexuality | 1 | 2011 | 202 | 0.080 |
Why?
|
| Quality of Life | 2 | 2023 | 459 | 0.080 |
Why?
|
| Sexual Partners | 1 | 2011 | 308 | 0.080 |
Why?
|
| Risk-Taking | 1 | 2011 | 435 | 0.080 |
Why?
|
| Family Relations | 1 | 2008 | 45 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2008 | 79 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 964 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2008 | 110 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 394 | 0.080 |
Why?
|
| Endarterectomy, Carotid | 1 | 2007 | 1 | 0.080 |
Why?
|
| Drug Administration Schedule | 3 | 2015 | 145 | 0.080 |
Why?
|
| Body Weight | 3 | 2014 | 404 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2007 | 65 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 43 | 0.070 |
Why?
|
| Apolipoproteins B | 1 | 2006 | 18 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2016 | 30 | 0.070 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2006 | 8 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 87 | 0.070 |
Why?
|
| Demography | 1 | 2006 | 167 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2006 | 60 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2006 | 98 | 0.070 |
Why?
|
| Brain | 1 | 2013 | 1268 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 1530 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2011 | 541 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 358 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2006 | 228 | 0.070 |
Why?
|
| Forecasting | 2 | 2003 | 124 | 0.070 |
Why?
|
| Postmenopause | 1 | 2005 | 125 | 0.070 |
Why?
|
| Leuprolide | 1 | 2004 | 8 | 0.070 |
Why?
|
| Androstenedione | 1 | 2004 | 16 | 0.070 |
Why?
|
| Hypogonadism | 1 | 2004 | 21 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 531 | 0.060 |
Why?
|
| Pertussis Vaccine | 1 | 2004 | 2 | 0.060 |
Why?
|
| Bordetella pertussis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2004 | 10 | 0.060 |
Why?
|
| Whooping Cough | 1 | 2004 | 4 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2016 | 288 | 0.060 |
Why?
|
| Nurse's Role | 1 | 2004 | 31 | 0.060 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2018 | 3 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 570 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2004 | 107 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2023 | 15 | 0.060 |
Why?
|
| Energy Intake | 3 | 2011 | 160 | 0.060 |
Why?
|
| Muscle Fatigue | 1 | 2003 | 9 | 0.060 |
Why?
|
| Leg | 1 | 2003 | 20 | 0.060 |
Why?
|
| Prebiotics | 1 | 2023 | 2 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2003 | 63 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 165 | 0.060 |
Why?
|
| Hospitals, Urban | 1 | 2002 | 38 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 50 | 0.060 |
Why?
|
| Outpatients | 1 | 2002 | 33 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2006 | 469 | 0.060 |
Why?
|
| Interviews as Topic | 2 | 2018 | 356 | 0.050 |
Why?
|
| Lipoproteins, VLDL | 1 | 2021 | 3 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 213 | 0.050 |
Why?
|
| Mice | 4 | 2018 | 5668 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 841 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2015 | 333 | 0.050 |
Why?
|
| Dietary Supplements | 2 | 2014 | 196 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2021 | 61 | 0.050 |
Why?
|
| Exercise Test | 2 | 2016 | 68 | 0.050 |
Why?
|
| Physician Assistants | 1 | 2021 | 11 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 413 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2021 | 37 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 881 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2021 | 44 | 0.050 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2021 | 40 | 0.050 |
Why?
|
| Los Angeles | 2 | 2015 | 368 | 0.050 |
Why?
|
| Gender Identity | 1 | 2021 | 93 | 0.050 |
Why?
|
| Home Care Services | 1 | 2020 | 29 | 0.050 |
Why?
|
| Animals | 5 | 2018 | 14307 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 147 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2015 | 1318 | 0.050 |
Why?
|
| Risk Reduction Behavior | 1 | 2021 | 121 | 0.050 |
Why?
|
| Sexual Behavior | 2 | 2021 | 587 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2019 | 65 | 0.040 |
Why?
|
| Guideline Adherence | 2 | 2012 | 82 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 894 | 0.040 |
Why?
|
| Exercise | 2 | 2021 | 524 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 348 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 642 | 0.040 |
Why?
|
| Antimalarials | 1 | 2019 | 48 | 0.040 |
Why?
|
| Physicians | 1 | 2021 | 148 | 0.040 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2018 | 14 | 0.040 |
Why?
|
| Nurses | 1 | 2019 | 44 | 0.040 |
Why?
|
| Smoking | 2 | 2022 | 903 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 212 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2018 | 37 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 901 | 0.040 |
Why?
|
| Evidence-Based Medicine | 2 | 2008 | 92 | 0.040 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2018 | 49 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2018 | 72 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 370 | 0.040 |
Why?
|
| Age Factors | 2 | 2015 | 1007 | 0.040 |
Why?
|
| Stroke | 1 | 2021 | 274 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 628 | 0.040 |
Why?
|
| Phosphorus | 1 | 2017 | 64 | 0.040 |
Why?
|
| Decision Trees | 1 | 2016 | 18 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2016 | 22 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 51 | 0.040 |
Why?
|
| Health Personnel | 1 | 2018 | 200 | 0.040 |
Why?
|
| Patient Admission | 1 | 2016 | 40 | 0.040 |
Why?
|
| Child | 2 | 2015 | 2875 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 37 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2005 | 18 | 0.030 |
Why?
|
| Echocardiography | 1 | 2016 | 144 | 0.030 |
Why?
|
| Luteinizing Hormone | 2 | 2005 | 62 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2015 | 35 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 61 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 292 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 606 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 472 | 0.030 |
Why?
|
| Drug Implants | 1 | 2013 | 19 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 34 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2013 | 24 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 2013 | 50 | 0.030 |
Why?
|
| Reference Values | 2 | 2004 | 204 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 859 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2008 | 1003 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2012 | 33 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 253 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 66 | 0.030 |
Why?
|
| Austria | 1 | 2012 | 4 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2012 | 31 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 103 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2012 | 17 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2012 | 59 | 0.030 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2012 | 28 | 0.030 |
Why?
|
| Texas | 1 | 2013 | 299 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2011 | 21 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 2012 | 35 | 0.030 |
Why?
|
| Gestational Age | 1 | 2012 | 190 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 423 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2012 | 393 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 878 | 0.020 |
Why?
|
| Medicare | 1 | 2012 | 188 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 145 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2003 | 468 | 0.020 |
Why?
|
| Milk Banks | 1 | 2009 | 2 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 1802 | 0.020 |
Why?
|
| Motivation | 1 | 2012 | 415 | 0.020 |
Why?
|
| Home Nursing | 1 | 2008 | 7 | 0.020 |
Why?
|
| Community Networks | 1 | 2008 | 98 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2008 | 90 | 0.020 |
Why?
|
| Barium Sulfate | 1 | 2006 | 2 | 0.020 |
Why?
|
| Enema | 1 | 2006 | 9 | 0.020 |
Why?
|
| Myogenin | 1 | 2006 | 5 | 0.020 |
Why?
|
| Software | 1 | 2008 | 204 | 0.020 |
Why?
|
| Occult Blood | 1 | 2006 | 25 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2006 | 31 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2008 | 205 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 42 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2006 | 151 | 0.020 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2005 | 4 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2006 | 32 | 0.020 |
Why?
|
| Hematocrit | 1 | 2005 | 18 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 129 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 38 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 186 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2005 | 39 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2006 | 123 | 0.020 |
Why?
|
| Gels | 1 | 2005 | 41 | 0.020 |
Why?
|
| Biopsy | 1 | 2006 | 151 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2005 | 91 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 210 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2005 | 30 | 0.020 |
Why?
|
| Cell Division | 1 | 2006 | 296 | 0.020 |
Why?
|
| Health Status | 1 | 2008 | 356 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 58 | 0.020 |
Why?
|
| Drug Design | 1 | 2006 | 154 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2004 | 12 | 0.020 |
Why?
|
| Models, Nursing | 1 | 2004 | 9 | 0.020 |
Why?
|
| Workload | 1 | 2004 | 22 | 0.020 |
Why?
|
| Prostate | 1 | 2005 | 136 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2004 | 58 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2004 | 81 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 555 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 859 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2004 | 129 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 317 | 0.010 |
Why?
|
| Thigh | 1 | 2003 | 10 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 650 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 55 | 0.010 |
Why?
|
| Hormones | 1 | 2003 | 51 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 66 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 73 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 148 | 0.010 |
Why?
|
| Vaccination | 1 | 2004 | 259 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 330 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 165 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 790 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 562 | 0.010 |
Why?
|